Print

AVEG 029

NCT00001076

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID)
rgp120/HIV-1 SF-2,ALVAC-HIV MN120TMG strain (vCP205)
RandD/trials/Lists/ClinicalTrialsList
Canarypox Env gp120, TM gp41, gag, protease B MN/LAI; Protein Env gp120 B SF-2